Finding the Causes of the Concretion Between Asthma and Urticaria: A Narrative Review

Abstract

In recent years, asthma and urticaria have become more common globally, imposing a significant economic and health burden on communities everywhere. Th2 cells, mast cells, eosinophil and M2 macrophages are all part of type-2 immune response, which is characteristic of many forms of allergy and asthma. Biomarkers are essential for precision medicine because of the clarity they provide in the identification of disease endotype, clusters, specific diagnoses, therapeutic target selection and the tracking of therapy effectiveness. Accurately measuring the biomarkers requires a variety of tools, including dependable point-of-care systems. It is preferable to collect samples in a way that is both quick and non-intrusive. In recent years, researchers have placed a premium on identifying novel biomarkers of allergic diseases and asthma. There are a number of intriguing markers of urticaria and asthma, including eosinophils, immunoglobulin E (IgE), interleukin and vitamin D insufficiency. The latest findings on the biomarkers associated with asthma and chronic urticaria are summarised in this article.